Ventureast appoints Dr. Srikanth Sundararajan as partner for Ventureast Proactive Fund II

Ventureast, one of India’s longest standing early-stage Venture Capital firms, has appointed Dr. Srikanth Sundararajan as Partner to oversee investments of its recently launched Ventureast Fund II (VPFII). 

He brings with him 25+ years of innovative IT and entrepreneurial experience with a host of leading technology firms in India and the US. Until recently, Srikanth was a Venture Partner with Helion Venture Partners, and helped with their Fund 3 portfolio.

He was involved with companies such as BigBasket, ID Fresh, Rapid Value, Whatfix, PipeMonk, CubeIT, MOEngage, CrownIT, Seclore, and others.

Srikanth is also an active angel investor/mentor- companies he has backed include HyperVerge, DocsApp, Nexgen PMS, Innovaccer, Airwood, AtherEnergy, Affine Analytics, EnterpriseForce, Wowsome, Minjar, Fleximoney, Active.ai, 34th Cross, among others. 

He was also a part of the Google Launch Pad set of mentors, some notables that came out of here were Baby Chakra, Adwyze, & English Dost. He has also actively collaborated with the IBM BlueMix team, Nasscom's 10,000 Product Startup initiative, T-Hub, and IIITH's incubator and IITM Research Park initiatives.

In his new role, Dr. Srikanth Sundararajan will work closely with Ventureast’s earlier portfolio companies to help them scale their business operations, and also focus on the new tech fund VPF II. 

The first closing of VPF II was announced in September 2016, following which the fund has started investing in seed and early stage businesses. Investments by this fund will retain a strong focus on differentiation through technology, and not just ‘technology enablement’. 

VPFII focuses on both consumer tech and enterprise tech (SME needs); consumer tech being focused on urban and semi-urban plays in the context of healthcare, fintech, agri-tech, edutech; enterprise tech would be focused on local to global SaaS plays. VPF II’s investments till date include Indus OS, Find Me a Shoe and Celes Care.

Also Read

Stay in the know with our newsletter